Chiapponi Costanza, Schmidt Matthias, Faust Michael
General, Abdominal, Tumor and Transplant Surgery, University Hospital of Cologne, Cologne, DEU.
Endocrine Surgery, Evangelisches Klinikum Köln Weyertal, Cologne, DEU.
Cureus. 2021 Jun 23;13(6):e15854. doi: 10.7759/cureus.15854. eCollection 2021 Jun.
The optional use of a saturated solution of potassium iodide in the immediate preoperative period to reach euthyroidism is included both in the American Thyroid Association (ATA) and in the European Thyroid Association (ETA) guidelines for the treatment of Graves' disease (GD). The recent literature though, shows that it does not translate to more clinically meaningful differences in surgical outcome. In our experience, potassium iodide should not be seen as a means for reducing operative time or complications; it is an effective way for reaching euthyroidism quickly. Herein, we describe three selected cases in which concentrated potassium iodide 65 mg tablets - instead of a saturated solution - were administered for thyroid blocking preoperatively, as recommended in the event of a nuclear emergency. One of the patients was pregnant. After oral treatment with potassium iodide 130 mg daily (two pills), euthyroidism was reached in all three cases within 24 hours. There were no side effects and surgery was performed without complications. Although the current literature did not report a significant benefit concerning operative time and complications, in our opinion preoperative potassium iodide plays an important role in selected cases for reaching euthyroidism preoperatively quickly. Potassium iodide 65 mg tablets, which are recommended in case of a nuclear emergency, are a very effective alternative to saturated solutions, which are not always quickly available and generally need to be administered over seven to 10 days.
美国甲状腺协会(ATA)和欧洲甲状腺协会(ETA)针对格雷夫斯病(GD)的治疗指南均建议,在术前即刻可选择使用碘化钾饱和溶液以使甲状腺功能恢复正常。然而,近期文献表明,这并未转化为手术结果方面更具临床意义的差异。根据我们的经验,碘化钾不应被视为缩短手术时间或减少并发症的手段;它是快速实现甲状腺功能正常的有效方法。在此,我们描述三例特定病例,按照核应急情况下的建议,术前给予患者65毫克浓缩碘化钾片剂而非饱和溶液进行甲状腺阻滞。其中一名患者为孕妇。每日口服130毫克碘化钾(两片)进行治疗后,所有三例患者均在24小时内实现甲状腺功能正常。未出现副作用,手术也未发生并发症。尽管当前文献未报道在手术时间和并发症方面有显著益处,但我们认为术前碘化钾在特定病例中对于快速实现术前甲状腺功能正常起着重要作用。在核应急情况下推荐使用的65毫克碘化钾片剂,是饱和溶液的一种非常有效的替代物,饱和溶液并非总是能迅速获取,且通常需要给药7至10天。